Better glycemic control reduces complications associated with type 2 diabetes (T2D) by at least 50 percent; unfortunately, a large percentage of patients with this disease continue to exhibit poor glycemic...
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
Jonathon O. Russell, MD, answers our questions about his new study, which found that magnesium disorders may be a modifiable target in reducing the incidence of hypocalcemia after total thyroidectomy.
In this podcast, Timothy Bhattacharyya, MD, discusses declining trends in hip fractures seen over the last 40 years, how osteoporosis treatment efforts relate to these trends, and what factors have had the...
Ophthalmologist Sonal Tuli, MD, discusses the FDA’s recent approval of teprotumumab for thyroid eye disease and what this new drug adds to the treatment landscape for this condition.
Sarah J. Zader, MD, and Melissa A. Buryk, MD, answer our questions about their new study, which indicated a clear association between hyperthyroidism and mental health conditions in pediatric patients. ...
Results of a new study show that major weight loss has the same impact on diabetes remission whether through weight loss surgery or diet. In this Q&A, lead researcher Samuel Klein, MD, answers our...
In this podcast, Akira Sekikawa, MD, PhD, talks about his research on the association of atherosclerosis and bone mineral density in an international cohort of middle-aged men.
Carol Kirkpatrick, PhD, RDN, MPH, CLS, FNLA, reviews the clinical recommendations for low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other...
